] Filters: Author is Oliveira, C [Clear All Filters]
"Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo",
Marine Drugs, vol. 21, issue 5, pp. 302, doi:10.3390/md21050302, 2023.
"Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies",
Marine Drugs, vol. 20, issue 11, pp. 689, doi:10.3390/md20110689, 2022.
"Growth Factor-Free Vascularization of Marine-Origin Collagen Sponges Using Cryopreserved Stromal Vascular Fractions from Human Adipose Tissue",
Marine Drugs, vol. 20, issue 10, pp. 623, doi:10.3390/md20100623, 2022.
"Biomimetic Surface Topography from the Rubus fruticosus Leaf as a Guidance of Angiogenesis in Tissue Engineering Applications",
ACS Biomaterials Science & Engineering, vol. 8, doi:10.1021/acsbiomaterials.2c00264, 2022.
"Sulfated Seaweed Polysaccharides",
Polysaccharides of Microbial Origin, Eds. Oliveira J. M., Radhouani H., and Reis R. L., Springer, Cham, doi:doi.org/10.1007/978-3-030-35734-4_17-1, 2021.
"Marine-derived polymeric nanostructures for cancer treatment.",
Nanomedicine, vol. 16, issue 22, pp. 1931-1935, doi:10.2217/nnm-2021-0175, 2021.
"Angiogenic potential of airbrushed fucoidan/polycaprolactone nanofibrous meshes",
International Journal Of Biological Macromolecules, vol. 183, pp. 695-706, doi:10.1016/j.ijbiomac.2021.04.166, 2021.
"A new vascular graft using the decellularized human chorion membrane",
ACS Biomaterials Science & Engineering, vol. 7, issue 7, pp. 3423–3433, doi:10.1021/acsbiomaterials.1c00293, 2021.
"Marine-derived biomaterials for cancer treatment",
Material Today, Biomaterials for 3D Tumor Modeling, Eds. Kundu S. C., and Reis R. L., ELSEVIER, pp. 551-576, doi:doi.org/10.1016/B978-0-12-818128-7.00023-X, 2020.
"Marine-origin Polysaccharides for Tissue Engineering and Regenrative Medicine, Chitosan and Fucoidan as illustrative examples"",
Encyclopedia of Marine Biotechnology, Eds. Kim S. - K., Wiley, vol. IV, pp. 2619-2650, doi:https://doi.org/10.1002/9781119143802.ch118, 2020.
"Spatial immobilization of endogenous growth factors to control vascularization in bone tissue engineering",
Biomaterials Science, vol. 8, issue 9, pp. 2577-2589, doi:10.1039/D0BM00087F, 2020.
"In vivo assessment of a novel biodegradable ureteral stent",
World Journal Of Urology, doi:10.1007/s00345-017-2124-3, 2017.
"In vitro and ex-vivo permeability studies of paclitaxel and doxorubicin from drug-eluting biodegradable ureteral stents",
Journal Of Pharmaceutical Sciences, doi:10.1016/j.xphs.2017.02.023, 2017.
"Polymeric substrates with immobilized antibodies and method of production thereof. ",
App nr. US 2017/0051050 A1, Priority date: 28/04/2014, 2017.
"Ureteral Stents Technology: Biodegradable and Drug-Eluting Perspective ",
Reference Module in Materials Science and Materials Engineering, Eds. Ducheyne P., Healy K. E., Hutmacher D. E., Grainger D. W., and Kirkpatrick C. J., Elsevier , doi:10.1016/B978-0-12-803581-8.10189-4, 2017.
"Gelatin-based Biodegradable Ureteral Stents For The Treatment Of Urothelial Tumors Of The Upper Urinary Tract Cancer",
Tissue Engineering Part A, vol. 22, issue S1, doi:10.1089/ten.tea.2016.5000.abstracts., 2016.
"Drug-eluting biodegradable ureteral stent: New approach for urothelial tumors of upper urinary tract cancer",
International Journal of Pharmaceutics, 00, vol. 00, issue 00, pp. 00, doi:10.1016/j.ijpharm.2016.08.061, 2016.
"Gelatin-based biodegradable ureteral stents with enhanced mechanical properties",
Applied Materials Today, vol. 9, pp. 9-18, doi:10.1016/j.apmt.2016.07.006, 2016.
"Upper urinary tract urothelial tumours targeted with biodegradable drug-eluting stents",
ESUT 2016, vol. 15, issue 6, pp. 181, doi:10.1016/S1569-9056(16)15141-3, 2016.
"Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer",
European Cells and Materials, vol. 31, issue 1, pp. 68, 2016.
"Biodegradable drug-eluting stents: Targeting urothelial tumors of upper urinary tract",
Journal of Urology, doi:10.1016/j.juro.2016.02.729, 2016.
"Biomaterials and tissue engineering: potential applications in surgery",
MASTERCLASS INNOVATIONS IN MINIMALLY INVASIVE UROLOGIC SURGERY, 2016.
"Targeting urothelial tumors of upper urinary tract with drug-eluting stents impregnated by supercritical fluids",
Front. Bioeng. Biotechnol. , doi:10.3389, 2016.
"Biodegradable drug-eluting stents: Targeting urothelial tumors of upper urinary tract",
European Urology Supplements, 15, vol. 15, issue 3, doi:10.1016/S1569-9056(16)60940-5, 2016.
"Ketoprofen-eluting biodegradable ureteral stents by CO2 impregnation: in vitro study",
International Journal of Pharmaceutics, 2, vol. 495, pp. 651-659, doi:10.1016/j.ijpharm.2015.08.040, 2015.
"Polymeric substrates with immobilized antibodies and method of production thereof. ",
WO/2015/166414, App nr. PCT/IB2015/053091, Priority date: 28/04/2014, 2015.
"A composition for ureteral stent and the method thereof",
15169249.8, 2015.
